Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBec…

Eli Lilly is negotiating to acquire AtaiBeckley Inc., a New York-based psychedelic medicine company, indicating a rising interest from major pharmaceutical firms in this emerging sector. The deal could be announced soon, highlighting the industry's shift towards psychedelic treatments.

US Stocks:

Waning Retail Conviction

Stock Movers Podcast

BackForward

Industries

Health

FacebookXLinkedIn

EmailLink

Gift

FacebookXLinkedIn

EmailLink

GiftGift this article

Confidential tip?\ Send a tip to our reporters

Site feedback:\ Take our SurveyNew Window

FacebookXLinkedIn

EmailLink

Gift

By Eyk Henning and Madison Muller

July 15, 2026 at 6:46 PM EDT

Updated on July 16, 2026 at 4:47 AM EDT

BookmarkSave

Eli Lilly & Co. is in talks to acquire AtaiBeckley Inc., according to people familiar with the matter, underscoring growing interest from large drugmakers in the once-fringe area of psychedelic medicine.

The pharmaceuticals group could announce a takeover of the New York-based drugmaker as soon as this week, the people said, asking not to be identified because the information is private.

Before it's here, it's on the Bloomberg Terminal\ \ Bloomberg Terminal LEARN MORE

Read Original at Bloomberg.com →

Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley